Language selection

Government of Canada / Gouvernement du Canada

Search

Possible "costs" and "savings" to the provinces of Bill C-22.: RG47-19/1986E-PDF

"Bill C-22 provides for a transitional phase-in of the periods of market exclusivity. Because provincial governments have been expecting a number of generic drugs to be on the market sooner than the Bill provides for, there will be transitional adjustment assistance to the provincial governments of $100 million over 4 years. This note derives the possible "cost" estimate based on a "worst case scenario" basis. In addition, it reports the possible savings to consumers due to the presence of the Drug Prices Review Board"--Introduction.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.883873&sl=0

Publication information
Department/Agency
  • Canada. Consumer and Corporate Affairs Canada, issuing body.
TitlePossible "costs" and "savings" to the provinces of Bill C-22.
Publication typeMonograph
Language[English]
FormatDigital text
Electronic document
Note(s)
  • Digitized edition from print [produced by Innovation, Science and Economic Development Canada].
Publishing information
  • [Ottawa] : Consumer and Corporate Affairs Canada, Bureau of Policy Coordination = Consommation et corporations Canada, Bureau de la coordination des politiques, [1986]
Description1 online resource (5 pages)
Catalogue number
  • RG47-19/1986E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: